Replies to post #81775 on Anavex Life Sciences Corp (AVXL)

[McMagyar]

That would be brilliant.

[drv17]

I had a similar wish also, but in checking FDA trials for Biogen I found two trials with their aducanumab (BIIB037) drug. One trial labelled ENGAGE and the other labelled EMERGE. I could not see any difference with a quick review of the trials unless it is eligibility of participants that I didn't look at closely or possibly different placebos.
Both trials are monthly infusion of aducanumab compared to a placebo. Both trials were started in Sept. 2015 and the latest updates were November 30 2016. These are studies are double blinded.
Perhaps someone with knowledge of trials could determine if what you (and I) were hoping for is a possibility.

I thought I remembered that someone posted that Biogen's drug was very effective in removing plaque and that a trial failure was based on something else. I could not find that info in a recent search however.